TNFRSF10B and gastric cancer: The immunohistochemistry (IHC) of DR5 in the nucleus in 190 gastric cancer patients showed that patients with positive DR5 expression in the nucleus of gastric cancer cells had a worse OS outcome (P = 0.020).